XENT
XENT Real Time Price USDRecent trades of XENT by members of U.S. Congress
| Politician | Type | Traded |
|---|---|---|
| Donna E. Shalala House / D | Purchase $1,001 - $15,000 | Mar. 06, 2019 |
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by XENT's directors and management
Government lobbying spending instances
-
$10,000 Aug 08, 2017 Issue: Health Issues
-
$10,000 Apr 20, 2015 Issue: Health Issues
-
$10,000 Jan 20, 2015 Issue: Health Issues
-
$10,000 Jan 20, 2015 Issue: Health Issues
-
$80,000 Oct 20, 2014 Issue: Medicare/Medicaid Health Issues
-
$50,000 Oct 20, 2014 Issue: Health Issues
Estimated quarterly lobbying spending
XENT Revenue by Segment or Geography
New patents grants
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Recent insights relating to XENT
Number of mentions of XENT in WallStreetBets Daily Discussion
Recent picks made for XENT stock on CNBC
ETFs with the largest estimated holdings in XENT
|
Shareholder
|
Shares Held
|
|---|
- Who owns $XENT stock?
- Who owns the most shares of $XENT stock?
- What funds own $XENT stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view XENT Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.